Announced the appointments of Mark Iwicki as Chief Executive Officer, Chris Cabell, M.D., M.H.S, FACC, as President and Head ...

Confirmed overall response rate (cORR) of 35% and median duration of response (mDOR) >5.6 months (not yet reached) observed in OncoSignature-positive (BM+) patients, a majority of whom were refractory ...

Good day, and welcome to the Kolibri Global Energy's First Quarter 2025 Financial Conference Call. [Operator Instructions] Please note, this event is being recorded. I advise participants that this ...